Hinova Pharma is an innovative drug research and development manufacturer that provides users with compound HC-1119 androgen receptor (AR) antagonism by using drug discovery systems such as medicinal chemistry, biological screening, process research, quality research, clinical reporting, and clinical research. Drugs, HC-1102 androgen receptor inhibitors and other products, for the treatment of advanced prostate cancer and breast cancer.

Tianjin Institute of Pharmaceutical Research Co., Ltd. engages in the in the development of various new products such as innovative drugs, generic drugs, new preparations, traditional Chinese medicines, and biological drugs with particular emphasis on the engineering and industrialization of new technologies to meet drug registration requirements. The company was founded in 1959 and is headquartered in Tianjin, China.

J-Pharma’s mission is to help mankind by creating and developing novel pharmaceuticals based upon a human-genomic approach; an approach where people with specific diseases are treated with novel and selective agents. J-Pharma’s intellectual property (IP) embraces the notion that cell membrane transporters are tightly associated to many diseases. In addition to drug molecules that target specific transporters, J-Pharma has discovered several important drug transporters within the human body that may be used to evaluate and optimize pharmacokinetics of new drug candidates. We believe that J-Pharma’s pipelines will lead to new agents and processes (i.e. diagnostic methods) and will increase the quality of life for an ageing population in industrialized countries. J-Pharma’s overall goal is to contribute globally to the maintenance of human health and improve human welfare through the creation of new drugs.

Zhejiang Xitang Industrial Co., Ltd. is a Chinese private company. The firm provides park infrastructure construction services.

Shandong Xingqiang Industrial Technology Research Institute Co., Ltd., established on 2019-10-25, Business scope includes petrochemical new technologies,New technologies in related fields such as petrochemical and new chemical materials,Research and development of new products,Application and sales;Testing service;Scientific Research and Technical Services;technology R & D,Technical service and achievement transformation;Security Risk Assessment Service;Environmental Impact Assessment Services;Safety establishment condition evaluation;Energy saving evaluation and energy saving,Consulting services for new energy and resource utilization;Chemical Industry Incubator,product service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Japan Tobacco, Inc. engages in the manufacture and sale of tobacco, pharmaceutical and processed food products. It operates through the following divisions: Japanese Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. The Japanese Domestic segment deals with the production and sale of tobacco products in domestic areas. The International Tobacco segment manufactures and markets tobacco products worldwide. The Pharmaceutical segment develops, manufactures, and sells prescription drugs. The Processed Food segment offers processed food, bakery products and seasonings. The company was founded on April 1, 1985 and is headquartered in Tokyo, Japan.

Nanjing Mingde New Drug Research and Development Co., Ltd., established on 2011-12-16, The scope of business includes engaging in pharmaceutical,Biological product,medical instruments,food development,Research;Environmental and pesticide testing services;Pharmaceutical Small Molecule Compound Library,Preclinical studies of drug leads and drug products,Technology development related to process development and clinical research,Technology introduction,Technical Services,Technical consulting and technology transfer,related technology,Licensing of Patents and Intellectual Property,Achievement Transformation and Transfer;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval)

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. engages in pharmaceutical research and development, manufacturing and sales, pharmaceutical modern logistics, health industry, and medical manufacturing and sales of beauty product. It offers Chinese patent drug, immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, antibiotic drugs, medical cosmetology, and scientific research equipment. The company was founded on December 31, 1992 and is headquartered in Hangzhou, China.

Chongqing Xingfa Golden Crown Chemical Co., Ltd., established on 2005-05-18, Business scope includes production,Sales:carbon disulfide(50000t/a,Natural gas non-catalyst method,heating furnace,reactor,condenser);Dimethyl sulfoxide(20000t/a,oxidative synthesis,synthesis reactor,Oxidation tower,Evaporator);Dimethyl sulfone(2000t/a,oxidative synthesis,synthesis reactor,Oxidation tower,Evaporator);Dimethyl sulfide(16000t/a,oxidative synthesis,synthesis reactor,Oxidation tower,Evaporator);Bill wholesale:General Hazardous Chemicals:Methanol,Dinitrogen tetroxide,sodium hydroxide solution,sulfur(Engage in business according to the approved items and time limit of the license).***Production,Sales:Dimethyl sulfoxide products and other chemical products;Sales of chemical raw materials(Free of Hazardous Chemicals);Manage the export business of the company's self-produced products,Import business of raw and auxiliary materials required for the production of the enterprise(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).***

Shenzhen Laibao Biotechnology Co., Ltd., established on 2019-07-09, Business scope includes general business items:Fine Chemicals,Chemical API,biological products,Technology development of biomedicine,technical consulting,Technical Services,technology transfer;Domestic Trade;biological enzyme catalyst,biological reagent,Organic intermediate(Does not contain pre-licensed items and national prohibitions,limit,Eliminated items),Chemical raw materials(Hazardous chemicals and precursor chemicals are excluded)wholesale and retail;cosmetic,cleaning supplies,Other daily chemical products(Monitor Chemicals,Excluding hazardous chemicals)wholesale and retail;Import and export of goods and technology.,The licensing program is:cosmetic,Manufacture of cleaning supplies and other household chemical products(Monitor Chemicals,Excluding hazardous chemicals)

Shenzhen YingAnti Biotechnology Co., Ltd., established on 2019-07-09, Business scope includes general business items:Fine Chemicals,Chemical API,biological products,Technology development of biomedicine,technical consulting,Technical Services,technology transfer,Domestic Trade;biological enzyme catalyst,biological reagent,Organic intermediate(Does not contain pre-licensed items and national prohibitions,limit,Eliminated items),Chemical raw materials(Hazardous chemicals and precursor chemicals are excluded)wholesale and retail;cosmetic,cleaning supplies,Other daily chemical products(Monitor Chemicals,Excluding hazardous chemicals)wholesale and retail;Import and export of goods and technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments),The licensing program is:cosmetic,Manufacture of cleaning supplies and other household chemical products(Monitor Chemicals,Excluding hazardous chemicals).

Chongqing Shuangteng Chemical Co., Ltd., established on 2011-05-12, Business scope includes production:carbon black;Sales:carbon black,Chemical Products(Free of Hazardous Chemicals).(National law,Operation prohibited by administrative regulations;National law,Administrative regulations stipulate that the operation can only be carried out after obtaining a license,Business activities must be carried out within the approved scope and time limit with the license)***

Shandong Haiya Pharmaceutical Technology Co., Ltd., established on 2011-08-17, Business scope includes research and development of new pharmaceutical products,Sales,commissioned production,Technology Promotion,Technology Transfer and Consulting,Technical Services;Enterprise Management Information Consulting(No Securities,Futures Investment Consulting,Excluding consumer stored value and similar related businesses);Organize cultural and artistic exchange activities(Excluding commercial performances and performance brokers);Marketing;marketing planning;Conference Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)**

Wellstat Therapeutics Corporation is a privately-held biopharmaceutical company located in Gaithersburg, Maryland. Dedicated to the discovery, development and commercialization of innovative therapeutics that expand the frontiers of medicine, Wellstat Therapeutics Corporation is committed to improving the lives of patients with chronic and life-threatening diseases.\nWellstat Therapeutics's focus is in the following fields:\nOncology\nMetabolic Diseases\nNeurodegenerative Diseases\nNeurometabolic Diseases\nWellstat Therapeutics is developing an extensive and diverse pipeline of novel small molecule therapeutic agents. The Company owns a broad patent portfolio covering this technology and is constantly expanding its intellectual property estate. Wellstat Therapeutics' pipeline spans the stages of development from discovery through Phase III clinical trials.\nWellstat Therapeutics was founded in 1985. The Company has a highly talented management team with significant experience in drug discovery, development, and commercialization. Samuel J. Wohlstadter, a company founder and the Chief Executive Officer was also a founder of Amgen Inc., Applied Biosystems (currently a division of Applera Corporation), IGEN International Inc. (currently a subsidiary of Roche), BioVeris Corporation (currently a subsidiary of Roche), and Hyperion Catalysis International, Inc.\nWellstat Therapeutics employs dedicated scientists, business professionals and support personnel at its state-of-the-art facilities in Gaithersburg, Maryland. Wellstat Therapeutics is part of the Wellstat Group of Companies, one of the largest and leading bioscience employers in the Baltimore-Washington Metropolitan Area. The Wellstat Group of Companies has expertise in all stages of discovery research and development, including:\nChemistry\nCell and Molecular Biology\nDisease Models\nTranslational Biology\nClinical Research and Development\nProject Management\nRegulatory Quality Assurance and Control\nManufacturing\nLegal and Financial

Jiangsu Hengrui Pharmaceuticals Co., Ltd. engages in the research, development, manufacture, and sale of drugs. It specializes in antineoplastic agents, surgical anesthesia drugs, features infusion, contrast agents, and cardiovascular drugs. The firm’s products include tablets, oral solution, and suspension of antineoplastic drugs and narcotic drugs; psychotropic substances; soft capsules; freeze-dried powder injection; powder injection; high-volume injection, including multi-layer co-extruded infusion bag, with anti-tumor drugs; small volume injections, including antineoplastic drugs, psychotropic drugs, and non-final sterilization; biological engineering products such as polyethylene glycol recombinant human granulocyte stimulating factor injection; hard capsules; granules; powder; and film and gel. The company was founded in 1970 and is headquartered in Lianyungang, China.

Suzuki Motor Corporation is a manufacturer and retailer of automobiles and automobile parts.

Guangdong Saifeng Pharmaceutical Technology Co., Ltd., established on 2014-05-05, Business scope includes medical research and experimental development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Pharmaceutical commissioned production;Drug import and export;Technology Import and Export;Inspection and testing service;

Jiangsu Ailikang Pharmaceutical Technology Co., Ltd., established on 2015-07-13, Business scope includes drug research and development;biochemical reagents;Biodiagnostic Reagents,Pharmaceutical carrier material,R&D and sales of pharmaceutical intermediates;Related technical consultation,Technical Services,technology transfer;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts the company to operate or prohibits the import and export of).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Dongbao Zixing (Hangzhou) Biopharmaceutical Co., Ltd., established on 2021-02-03, Business scope includes licensed projects:pharmaceutical production;Drug retail;Drug Wholesale;Production of Class II Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Medical Research and Experimental Development;Sales of Class II Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Westlake Therapeutics (Hangzhou) Co., Ltd. is a Chinese company located in Hangzhou that provides clinical research and cell therapy services. The firm was founded in 2019 by Xiao Fei Gao.